DVA
73
2
AAP
27
3
WU
44
-2
AIV
62
-2
BXP
52
-2
UHS
60
-3
GOOG
75
2
SNA
60
2
DNB
46
-2
UA
35
-13
URI
63
3
WM
80
-4
STI
15
-5
PEG
55
2
APA
30
5
WY
36
5
MDLZ
46
-4
CAT
69
3
STX
59
-5
FCX
67
14
DVA
73
2
AAP
27
3
WU
44
-2
AIV
62
-2
BXP
52
-2
UHS
60
-3
GOOG
75
2
SNA
60
2
DNB
46
-2
UA
35
-13
URI
63
3
WM
80
-4
STI
15
-5
PEG
55
2
APA
30
5
WY
36
5
MDLZ
46
-4
CAT
69
3
STX
59
-5
FCX
67
14
Financhill
Back

Amplify Treatments, Testing and Adv ETF Stock Predictions

Buy
59

GERM
Amplify Treatments, Testing and Adv ETF

Last Price:
19.06
Seasonality Move:
10.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Amplify Treatments, Testing and Adv ETF Stock Forecast

  • Over the next 52 weeks, Amplify Treatments, Testing and Adv ETF has on average historically fallen by 18.2% based on the past 3 years of stock performance.
  • Amplify Treatments, Testing and Adv ETF has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Amplify Treatments, Testing and Adv ETF Stock Undervalued?
    The current Amplify Treatments, Testing and Adv ETF [GERM] share price is $19.23. The Score for GERM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • GERM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Amplify Treatments, Testing and Adv ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Amplify Treatments, Testing and Adv ETF has on average historically fallen by 18.2% based on the past 3 years of stock performance.

Amplify Treatments, Testing and Adv ETF Stock Rating

Buy
59
Amplify Treatments, Testing and Adv ETF (GERM) is a Buy

Is Amplify Treatments, Testing and Adv ETF overpriced?

  • Amplify Treatments, Testing and Adv ETF has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Amplify Treatments, Testing and Adv ETF Stock Price History

Is GERM stock going to rise?

  • The current trend is moderately bullish and GERM is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
21.48
52-Week Low:
15.67

Prediction Charts

Market Cap:
0
Price in USD:
19.23
Volume:
274
Beta:
0.97

Technical Analysis

SMA50:
17.89
SMA100:
18.34
SMA200:
18.15
52-Wk Change:
-6.86%

Stock Predictions

  • Is Amplify Treatments, Testing and Adv ETF stock public?
    Yes, Amplify Treatments, Testing and Adv ETF is a publicly traded company.
  • What is the Amplify Treatments, Testing and Adv ETF stock quote today?
    The Amplify Treatments, Testing and Adv ETF stock price is 19.23 USD today.
  • How to buy Amplify Treatments, Testing and Adv ETF stock online?
    You can buy Amplify Treatments, Testing and Adv ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-30 17.43 17.28 17.43 17.28
May-1 17.49 17.73 17.83 17.46
May-2 17.82 18.14 18.14 17.82
May-3 18.29 18.40 18.40 18.29
May-6 18.49 18.33 18.49 18.33
May-7 18.34 18.27 18.34 18.27
May-8 17.63 18.03 18.03 17.50
May-9 18.03 18.07 18.07 18.03
May-10 18.13 18.21 18.48 18.07
May-13 18.39 18.97 18.99 18.39
May-14 19.10 19.04 19.18 19.02
May-15 19.06 19.18 19.30 19.06
May-16 19.27 19.48 19.55 19.27
May-17 19.22 19.23 19.23 19.22

Amplify Treatments, Testing and Adv ETF Earnings

Data Unavailable

Amplify Treatments, Testing and Adv ETF Forecast Revenue Growth

Data Unavailable

* Amplify Treatments, Testing and Adv ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.